Brenda J. Hefti
Senior VP & General CounselDr. Brenda J. Hefti, J.D., Ph.D. is Senior VP & General Counsel of Exelixis, Inc. from November 7, 2025. Dr. Hefti joined Exelixis in 2013 as corporate counsel, was promoted to the Head of IP in 2014 and served as Senior Vice President, IP & Licensing since 2020. From 2010 to 2013, Dr. Hefti served as Assistant Director, Industry Contracts at the University of California, San Francisco (UCSF), where she led negotiations for several strategic partnerships between UCSF and pharmaceutical companies and worked on research and clinical transactions, patent strategy and licensing. From 2008 to 2010, Dr. Hefti was an Associate at Wilson Sonsini Goodrich & Rosati, LLP, where she advised public and private medical device and biotechnology companies on corporate governance, mergers and acquisitions, public company reporting and private equity and debt financings. Dr. Hefti received her J.D. from the University of California School of Law and is admitted to practice in California and before the U.S. Patent and Trademark Office. She received her Ph.D. in Neuroscience from the University of Wisconsin, Madison and holds B.A.s in Molecular and Cell Biology and English Literature from the University of California, Berkeley.
Positions
- Company NameExelixis, Inc.Stock CodeEXELPositionSenior VP & General CounselColleagues
- SPStelios PapadopoulosCo-Founder & Independent Chair of the Board
- MMMichael M. MorrisseyCEO, President & Director
- CJChristopher J. SennerExecutive VP & CFO
- DTDana T. AftabExecutive Vice President of Research & Development
- JLJack L. WyszomierskiIndependent Director
- JAJulie Anne SmithIndependent Director
- MCMaria C. FreireIndependent Director
